pyrrolidonecarboxylic acid has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, M; Maeda, J; Mori, T; Shimada, H; Shinotoh, H; Suhara, T; Ueno, S | 1 |
| Franke, I; Gelderblom, M; Glassmeier, G; Ignatov, A; Imai, Y; Rezgaoui, M; Schaller, HC; Süsens, U; Takahashi, R; Urny, J | 1 |
1 review(s) available for pyrrolidonecarboxylic acid and Parkinson Disease
| Article | Year |
|---|---|
Molecular imaging of dementia.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Humans; Immunization; Lewy Body Disease; Mice; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Pyrrolidonecarboxylic Acid; tau Proteins | 2012 |
1 other study(ies) available for pyrrolidonecarboxylic acid and Parkinson Disease
| Article | Year |
|---|---|
The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37.
Topics: Animals; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Chlorocebus aethiops; COS Cells; Humans; Mitogens; Neuropeptides; Oocytes; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Transfection; Xenopus laevis | 2006 |